OncoDNA

OncoDNA is a Belgium-based genomic and theranostic company focused on precision medicine for cancer and genetic diseases.

Founded in December 2012 and headquartered in Gosselies, Belgium, the company aims to enhance patient outcomes by providing cancer molecular profiling that helps tailor therapy decisions. OncoDNA's offerings include cancer biomarker tests, genomic services in oncology, and data interpretation tools. Key products feature OncoDeep, a next-generation sequencing assay for comprehensive genomic profiling, and various specialized tools like OncoStrat&Go and OncoKDM for treatment stratification and clinical insights. The company also provides SaaS-based interpretation software to laboratories worldwide, enabling them to convert raw oncology data into actionable clinical insights. OncoDNA serves a diverse international clientele, including clinical and research centers, laboratories with NGS technology, and the biopharma industry. The company operates through two main entities, BioSequence and IntegraGen, and employs around 100–120 people across multiple countries. With a strong focus on B2B services and a commitment to advancing therapeutic innovation, OncoDNA continues to play a significant role in the field of precision medicine.